![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 42, 29633-29640, October 15, 1999
and
Light
Chains
,
, and
From the In previous studies we showed that the plasma
protein histidine-rich glycoprotein (HRG) binds strongly to pooled
human IgG. In the present work myeloma proteins consisting of different
human IgG subclasses were examined for their ability to interact with human HRG. Using an IAsys optical biosensor we found initially that IgG
subclasses differ substantially in their affinity of interaction with
HRG. However, the most striking finding was the observation that the
kinetics of the HRG interaction was dramatically affected by whether
the IgG subclasses contained the
Division of Immunology and Cell Biology,
or
light (L)-chains. Thus, the
on-rate for the binding of HRG to the
L-chain containing IgG1 and
IgG2 (IgG1
and IgG2
) was ~4- and ~10-fold faster than that
for the binding of HRG to
L-chain containing IgG1 and IgG2 (IgG1
and IgG2
), respectively, with the dissociation constants
(Kd) in the range 3-5 nM and 112-189
nM for the
and
isoforms, respectively. In contrast, the on-rate for the binding of HRG to IgG3
and IgG4
was found to
be 9- and 20-fold slower than that for the binding of HRG to IgG3
and IgG4
, respectively, with the Kd in the range 147-268 nM and 96-109 nM for the
and
isoforms, respectively. The binding of HRG to immunoglobulins
containing the
L-chain (particularly IgG1
) was generally
potentiated in the presence of a physiological concentration (20 µM) of Zn2+ (Kd decreased
to 0.60 ± 0.01 for IgG1
), but Zn2+ had no effect
or slightly inhibited the binding of HRG to immobilized IgG subclasses
possessing the
L-chain. Interestingly, HRG also bound
differentially to Bence Jones (BJ) proteins containing
and
L-chains, with HRG having a 14-fold lower Kd for BJ
than for BJ
when 20 µM Zn2+ was
present. HRG also bound to IgM (IgM
), but the affinity of this
interaction (Kd ~1.99 ± 0.05 µM) was markedly lower than the interaction with IgG, and
the affinity was actually decreased 4-fold in the presence of
Zn2+. The results demonstrate that both the heavy (H)- and
L-chain type have a profound effect on the binding of HRG to different IgG subclasses and provide the first evidence of a functional difference between the
and
L-chains of immunoglobulins.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
This article has been cited by other articles:
![]() |
T. M. Dillon, M. S. Ricci, C. Vezina, G. C. Flynn, Y. D. Liu, D. S. Rehder, M. Plant, B. Henkle, Y. Li, S. Deechongkit, et al. Structural and Functional Characterization of Disulfide Isoforms of the Human IgG2 Subclass J. Biol. Chem., June 6, 2008; 283(23): 16206 - 16215. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Jones, I. K. H. Poon, M. D. Hulett, and C. R. Parish Histidine-rich Glycoprotein Specifically Binds to Necrotic Cells via Its Amino-terminal Domain and Facilitates Necrotic Cell Phagocytosis J. Biol. Chem., October 21, 2005; 280(42): 35733 - 35741. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Jones, M. D. Hulett, J. G. Altin, P. Hogg, and C. R. Parish Plasminogen Is Tethered with High Affinity to the Cell Surface by the Plasma Protein, Histidine-rich Glycoprotein J. Biol. Chem., September 10, 2004; 279(37): 38267 - 38276. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Jones, M. D. Hulett, and C. R. Parish Histidine-rich Glycoprotein Binds to Cell-surface Heparan Sulfate via Its N-terminal Domain following Zn2+ Chelation J. Biol. Chem., July 16, 2004; 279(29): 30114 - 30122. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tsurupa, B. Ho-Tin-Noe, E. Angles-Cano, and L. Medved Identification and Characterization of Novel Lysine-independent Apolipoprotein(a)-binding Sites in Fibrin(ogen) {alpha}C-domains J. Biol. Chem., September 26, 2003; 278(39): 37154 - 37159. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. N. Gorgani, B. A. Smith, D. H. Kono, and A. N. Theofilopoulos Histidine-Rich Glycoprotein Binds to DNA and Fc{gamma}RI and Potentiates the Ingestion of Apoptotic Cells by Macrophages J. Immunol., November 1, 2002; 169(9): 4745 - 4751. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Manderson, M. C. Pickering, M. Botto, M. J. Walport, and C. R. Parish Continual Low-Level Activation of the Classical Complement Pathway J. Exp. Med., September 10, 2001; 194(6): 747 - 756. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. MEDVED, G. TSURUPA, and S. YAKOVLEV Conformational Changes upon Conversion of Fibrinogen into Fibrin: The Mechanisms of Exposure of Cryptic Sites Ann. N.Y. Acad. Sci., June 1, 2001; 936(1): 185 - 204. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |